about
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitisVirus-like particles: a new family of delivery systems.Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.HPV in HIV-Infected Women: Implications for Primary PreventionRecent advances in diagnosis and therapy of human papillomaviruses.The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivoLife cycle heterogeneity in animal models of human papillomavirus-associated diseaseHuman papillomavirus: clinical significance and malignant potential.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Papillomavirus-like particle based vaccines: cervical cancer and beyond.Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig modelDevelopment of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.Preventative and therapeutic vaccines for cervical cancer.Evaluating human papillomavirus vaccination programs.Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.Human papillomavirus, condylomata acuminata, and anal neoplasia.Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.Human papillomavirus type-16 variants in Quechua aboriginals from Argentina.Microelectromechanical system-based diagnostic technology for cervical cancer.Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province.
P2860
Q27469459-92A81560-937C-4431-A9AF-A34B3E99F057Q30817169-59649002-B95F-4549-B750-A6F0675D601EQ33853398-4BDD0B4C-50BA-47BE-8BE1-CAAC4D9FFECDQ34033445-D9B00288-54EC-44F0-8F7F-7D955B647BF4Q34074998-85E6947F-69F0-49D3-80D5-A408A006678DQ34293109-AE3107B8-7552-4A00-A494-DDA505C66C6AQ34348189-7A0806DA-F5AB-46E1-A8E4-0340CC875EC6Q34394146-06BA66E6-0498-4D26-A6CE-AF0D2A4E4114Q34434903-144B9CFD-3CB7-47F8-9EB7-B51553844CFEQ34451862-6B1B952B-E019-42B7-BD03-B1633D0CF364Q34579346-9FC893EA-F89B-4256-A346-AAFC7CA4FBFBQ35077753-7449640D-5E84-4C4D-98A5-825FC1D99FFFQ35498376-C3670E1A-48F4-468D-9A3C-BE9CAD62C37FQ35552591-023BA65E-F17E-447B-B60B-F725DF877D6CQ35623323-05540D14-8C24-4F03-B80F-FC86CCC22B85Q35895952-C69CB886-6774-494D-97FC-4305F2BA9A6AQ36888054-379E1F4D-A32C-4531-BEFD-FF3A0D50CCA1Q37427460-FDA0BE73-FACC-4D68-8BD9-3FCEF313CEA6Q39606511-A3759EB6-9789-4998-B4E5-D31B54FF1B83Q39742082-E0273A2C-CB50-4DCB-84A2-402EA4D7C1FCQ48258370-5EE9221C-580F-4323-99D3-5A5EBC31B445Q51546439-F55DF588-65B1-4431-8182-7D615A893BA2Q51574377-1B81127E-29A6-4FCD-8D7B-2CE19F0986A0
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human papillomavirus vaccines.
@ast
Human papillomavirus vaccines.
@en
type
label
Human papillomavirus vaccines.
@ast
Human papillomavirus vaccines.
@en
prefLabel
Human papillomavirus vaccines.
@ast
Human papillomavirus vaccines.
@en
P356
P1476
Human papillomavirus vaccines.
@en
P2093
Breitburd F
Coursaget P
P304
P356
10.1006/SCBI.1999.0147
P577
1999-12-01T00:00:00Z